3rd Quarter - Report

WEST FRONT STRATEGIES LLC for VIATRIS INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to the intellectual property provisions in the Trans-Pacific Partnership negotiations.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Issues related to corporate tax reform.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Issues related to patent litigation reform, including H.R. 9, the Innovation Act; S. 632, the STRONG Patents Act; S. 1137, the PATENT Act; and, S. 2733, the Venue Equity and Non-Uniformity Elimination Act of 2016.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2733 (114th), S. 1137 (114th), H.R. 9 (114th), S. 632 (114th)

Health Issues HCR

Issues related to implementation of the Generic Drug User Fee Agreement; Issues related to H.R. 6, 21st Century Cures Initiative and Senate HELP Innovation Initiative; Issues related to epinephrine auto injectors; FDA proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; FDA proposed rule, Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products; Issues related to generic drug pricing; Access to epinephrine auto injectors on air carriers, H.R. 4441, Aviation Innovation, Reform, and Reauthorization Act of 2016, and S. 2658, Federal Aviation Administration Reauthorization Act of 2016; REMs program, H.R. 2841 FAST Generics Act and S.3056 CREATES Act.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4441 (114th), H.R. 2841 (114th), H.R. 6 (114th), S. 2658 (114th), S. 3056 (114th)

Budget/Appropriations BUD

FY 2017 Agriculture/FDA Appropriations, in particular, FDA funding and issues related to user fees; FY 2017 Labor/HHS Appropriations, in particular, issues related to Medicaid rebate for generic drugs.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues related to a Medicaid rebate for generic drugs, including provisions in the Bipartisan Budget Act of 2015 (H.R. 1314).

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1314 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.